The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein(a) levels in familial hypercholesterolemia

Metabolism: Clinical and Experimental

Volumn 45, Issue 11, 1996, Pages 1415-1421

  Tonstad, Serena ^a   Sundt, Elisabeth ^b   Ose, Leiv ^b   Hagve, Tor Arne ^b   Fruchart, Jean Charles ^b   Bard, Jean M ^b   Edén, Staffan ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY RISK; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME INHIBITION; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; HEART MUSCLE CONTRACTILITY; HUMAN; LIPOPROTEIN METABOLISM; MALE; MUSCLE MASS; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0029803954     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90124-9     Document Type: Article

References (43)

1. Goldstein JL, Hobbs HH, Brown MS: Familial hypercholesterolemia, in Scriver CR, Beaudet AL, Sly WS, et al (eds): The Metabolic and Molecular Bases of Inherited Disease (ed 7). New York, NY, McGraw-Hill, 1995, pp 1981-2030
2. Illingworth DR, Bacon S: Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs. Arteriosclerosis 9:1121-1134, 1989
3. Pierce LR, Wysowski DK, Gross TP: Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA 264:71-75, 1990
4. Salomon F, Cuneo RC, Hesp R, et al: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803, 1989
5. Edén S, Wiklund O, Oscarsson J, et al: Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 13:296-301, 1993
6. Cuneo RC, Salomon F, Watts GF, et al: Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism 42:1519-1523, 1993
7. Russell-Jones DL, Watts GF, Weissberger A, et al: The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol (Oxf) 41:345-350, 1994
8. Beshyah SA, Henderson A, Niththyananthan R, et al: The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab 80:356-363, 1995
9. Weaver JU, Monson JP, Noonan K, et al: The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 80:153-159, 1995
10. Rudling M, Norstedt G, Olivecrona H, et al: Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA 89:6983-6987, 1992
11. Olivecrona H, Ericsson S, Berglund L, et al: Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment. Br Med J 306:1726-1727, 1993
12. Hansen PS, Kassem M, Brixen K, et al: Effect of short-term treatment with recombinant human growth hormone on lipids and lipoproteins in women and men without growth hormone disturbances. Metabolism 44:725-729, 1995
13. Olivecrona H, Johansson AG, Lindh E, et al: Hormonal regulation of serum lipoprotein(a) levels. Arterioscler Thromb Vase Biol 15:847-849, 1995
14. Olivecrona H, Ericsson S, Angelin B: Growth hormone treatment does not alter biliary lipid metabolism in healthy adult men. J Clin Endocrinol Metab 80:1113-1117, 1995
15. Angelin B, Rudling M: Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipidol 5:160-165, 1994
16. Thuesen L, Jørgensen JOL, Müller JR, et al: Short- and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clin Endocrinol (Oxf) 41:615-620, 1994
17. Leren TP, Rødningen OK, Tonstad S, et al: Identification of the apo B-3500 mutation in the Norwegian population. Scand J Clin Lab Invest 55:217-221, 1995
18. Eiklid K, Leren TP: Genotyping of apolipoprotein E. Tidsskr Nor Laegeforen 31:545-548, 1993
19. Koren E, Puchois P, Alaupovic P, et al: Quantification of two different types of apolipoprotein AI containing lipoprotein particles in plasma by enzyme linked differential antibody immunosorbent assay. Clin Chem 33:38-43, 1987
20. Kandoussi A, Cachera C, Parsy D, et al: Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immunosorbent assay: Apo B with apo CIII and apo B with apo E. J Immunoassay 12:305-323, 1991
21. Fiskerstrand T, Refsum H, Kvalheim G, et al: Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 39:263-271, 1993
22. Sundsfjord JA, Thibault G, Larochelle P, et al: Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 66:605-610, 1988
23. Leren TP, Solberg K, Rødningen OK, et al: Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects. Atherosclerosis 111:175-182, 1994
24. Leren TP, Sundvold H, Rødningen OK, et al: Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia. Hum Genet 95:671-676, 1995
25. Oscarsson J, Ottosson M, Wiklund O, et al: Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men. Clin Endocrinol (Oxf) 41:109-116, 1994
26. Whitehead HM, Boreham C, McIlrath EM, et al: Growth hormone treatment of adults with growth hormone deficiency: Results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf) 36:45-52, 1992
27. Holloway L, Butterfield G, Hintz RL, et al: Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab 79:470-479, 1994
28. Connor WE, Connor SL: Importance of diet in the treatment of familial hypercholesterolemia. Am J Cardiol 72:43D-53D, 1993
29. Friedman M, Byers SO, Rosenman RH, et al: Hypocholesterolemic effect of human growth hormone in coronary-prone (type A) hypercholesterolemic subjects. Proc Soc Exp Biol Med 141:76-80, 1972
30. Friedman M, Byers SO, Rosenman RH, et al: Effect of subacute administration of human growth hormone on various serum lipid and hormone levels of hypercholesterolemic and normocholesterolemic subjects. Metabolism 23:905-912, 1974
31. Aloia JF, Zanzi I, Cohn SH: Absence of an effect of chronic administration of growth hormone on serum lipids. Metabolism 24:795-798, 1975
32. Eden S, Oscarsson J: Lipids and growth hormone, in Recent Advances in Growth Hormone and Growth Hormone Therapy, Serono Colloquia Europe, vol 2. Tel Aviv, Israel, Freund, 1995, pp 1-14
33. Beher WT, Beher ME, Semenuk G: The effect of pituitary and thyroid hormones on bile acid metabolism in the rat. Metabolism 15:181-188, 1966
34. Rader DJ, Mann WA, Cain W, et al: The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest 95:1403-1408, 1995
35. Seed M, Hoppichler F, Reaveley D, et al: Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 322:1494-1499, 1990
36. Oscarsson J, Lundstam U, Gustafsson B, et al: Recombinant human insulin-like growth factor-I decreases serum lipoprotein(a) concentrations in normal adult men. Clin Endocrinol (Oxf) 42:673-676, 1995
37. Shewmon DA, Stock JL, Rosen CJ, et al: Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women. Arterioscler Thromb 14:1586-1593, 1994
38. Tholstrup T, Marckmann P, Vessby B, et al: Effect of fats high in individual saturated fatty acids on plasma lipoprotein[a] levels in young healthy men. J Lipid Res 36:1447-1452, 1995
39. Blackett PR, Weech PK, McConathy WJ, et al: Growth hormone in the regulation of hyperlipidemia. Metabolism 31:117-120, 1982
40. Campos H, Genest JJ Jr, Blijlevens E, et al: Low density lipoprotein particle size and coronary artery disease: Arterioscler Thromb 12:187-195, 1992
41. Fruchart J-C, De Geteire C, Delfly B, et al: Apolipoprotein A-I-containing particles and reverse cholesterol transport: Evidence for connection between cholesterol efflux and atherosclerosis risk. Atherosclerosis 110:S35-S39, 1994 (suppl)
42. Genest JJ, Bard JM, Fruchart J-C, et al: Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease. Atherosclerosis 90:149-157, 1991
43. Rizza RA, Mandarino LJ, Gerich JE: Effects of growth hormone on insulin action in man. Diabetes 31:663-669, 1982